| Code | Description | Claims | Beneficiaries | Total Paid |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
12,360 |
11,953 |
$1.78M |
| G0378 |
Hospital observation service, per hour |
3,717 |
1,468 |
$912K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
3,280 |
3,126 |
$520K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
2,793 |
2,708 |
$250K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,386 |
1,349 |
$176K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
7,306 |
6,959 |
$131K |
| T1015 |
Clinic visit/encounter, all-inclusive |
4,257 |
3,865 |
$112K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
390 |
381 |
$93K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
464 |
453 |
$69K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
345 |
335 |
$59K |
| 95811 |
|
140 |
135 |
$59K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
393 |
389 |
$54K |
| 72141 |
|
244 |
232 |
$52K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
14,723 |
12,471 |
$50K |
| 73221 |
|
209 |
205 |
$49K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
249 |
244 |
$47K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
3,784 |
3,405 |
$45K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
8,794 |
7,217 |
$43K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
6,164 |
5,768 |
$39K |
| 80053 |
Comprehensive metabolic panel |
5,313 |
4,735 |
$36K |
| 70450 |
Computed tomography, head or brain; without contrast material |
914 |
879 |
$36K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
580 |
562 |
$33K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
31 |
27 |
$32K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
112 |
112 |
$29K |
| 84484 |
|
4,370 |
3,994 |
$27K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
481 |
466 |
$26K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
550 |
540 |
$26K |
| 71250 |
|
398 |
387 |
$23K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
462 |
434 |
$21K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
190 |
184 |
$20K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
322 |
320 |
$19K |
| 71045 |
Radiologic examination, chest; single view |
3,443 |
3,307 |
$17K |
| 80050 |
General health panel |
380 |
377 |
$14K |
| 62323 |
|
166 |
163 |
$14K |
| 80076 |
|
2,602 |
2,447 |
$14K |
| 83605 |
|
2,795 |
2,584 |
$14K |
| 84443 |
Thyroid stimulating hormone (TSH) |
781 |
764 |
$13K |
| 83880 |
|
650 |
619 |
$13K |
| 83690 |
|
3,875 |
3,640 |
$12K |
| 85730 |
|
2,896 |
2,761 |
$12K |
| 71046 |
Radiologic examination, chest; 2 views |
1,041 |
1,018 |
$11K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
361 |
325 |
$11K |
| 93971 |
|
222 |
211 |
$11K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
382 |
369 |
$11K |
| J3490 |
Unclassified drugs |
3,409 |
2,160 |
$11K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
254 |
244 |
$10K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
43 |
43 |
$10K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
721 |
467 |
$9K |
| 70496 |
|
88 |
86 |
$9K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
6,427 |
6,056 |
$9K |
| 76536 |
|
184 |
182 |
$8K |
| 85610 |
|
3,844 |
3,462 |
$8K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
417 |
340 |
$8K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
291 |
284 |
$7K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
136 |
132 |
$7K |
| Q3014 |
Telehealth originating site facility fee |
541 |
513 |
$7K |
| 80061 |
Lipid panel |
665 |
657 |
$7K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
175 |
170 |
$7K |
| 83735 |
|
1,868 |
1,471 |
$7K |
| 70498 |
|
69 |
67 |
$6K |
| 64721 |
|
13 |
13 |
$6K |
| 93970 |
|
132 |
124 |
$6K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
162 |
159 |
$6K |
| A9577 |
Injection, gadobenate dimeglumine (multihance), per ml |
1,393 |
1,357 |
$6K |
| 72100 |
|
330 |
328 |
$6K |
| 76830 |
Ultrasound, transvaginal |
148 |
145 |
$5K |
| 76770 |
|
186 |
180 |
$5K |
| 87040 |
|
549 |
358 |
$5K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,030 |
981 |
$5K |
| J1815 |
Injection, insulin, per 5 units |
715 |
353 |
$5K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
777 |
547 |
$5K |
| 93017 |
|
220 |
214 |
$5K |
| 71271 |
|
57 |
56 |
$5K |
| 82803 |
|
271 |
257 |
$4K |
| 84703 |
|
675 |
657 |
$4K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
494 |
491 |
$4K |
| 85379 |
|
611 |
598 |
$4K |
| 94729 |
|
182 |
179 |
$4K |
| 81001 |
|
2,161 |
2,067 |
$4K |
| 94726 |
|
181 |
178 |
$4K |
| 93226 |
|
116 |
114 |
$4K |
| 96158 |
|
91 |
56 |
$4K |
| 64415 |
|
13 |
13 |
$3K |
| 82565 |
|
894 |
869 |
$3K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
10,130 |
5,972 |
$3K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
694 |
686 |
$3K |
| 73560 |
|
323 |
311 |
$3K |
| J8501 |
Aprepitant, oral, 5 mg |
392 |
364 |
$3K |
| 82607 |
|
345 |
334 |
$3K |
| 73610 |
|
214 |
210 |
$3K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
6,453 |
3,047 |
$3K |
| 73030 |
|
258 |
252 |
$3K |
| 74178 |
|
14 |
14 |
$3K |
| 93975 |
|
26 |
26 |
$3K |
| 73630 |
|
347 |
336 |
$3K |
| 84439 |
|
421 |
410 |
$3K |
| 73502 |
|
204 |
201 |
$3K |
| 81025 |
|
1,088 |
1,055 |
$2K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
170 |
169 |
$2K |
| 82728 |
|
238 |
233 |
$2K |
| 86850 |
|
367 |
341 |
$2K |
| 96159 |
|
67 |
40 |
$2K |
| 74018 |
|
208 |
200 |
$2K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
39 |
39 |
$2K |
| 70486 |
|
40 |
39 |
$2K |
| 70491 |
|
28 |
28 |
$2K |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
1,132 |
1,038 |
$2K |
| 84100 |
|
674 |
513 |
$2K |
| 85027 |
|
777 |
551 |
$2K |
| 94060 |
|
194 |
191 |
$2K |
| J2785 |
Injection, regadenoson, 0.1 mg |
114 |
114 |
$2K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
64 |
58 |
$2K |
| 73130 |
|
217 |
208 |
$2K |
| 88342 |
|
78 |
78 |
$2K |
| 93225 |
|
116 |
114 |
$2K |
| 85652 |
|
758 |
701 |
$2K |
| 86140 |
|
705 |
648 |
$1K |
| 87186 |
|
311 |
295 |
$1K |
| 86618 |
|
96 |
93 |
$1K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
4,402 |
3,038 |
$1K |
| 83540 |
|
240 |
235 |
$1K |
| 86803 |
|
116 |
115 |
$1K |
| 87077 |
|
343 |
322 |
$1K |
| 82550 |
|
288 |
261 |
$1K |
| 82962 |
|
1,298 |
700 |
$1K |
| 84702 |
|
87 |
73 |
$1K |
| 84134 |
|
77 |
73 |
$1K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
2,078 |
1,651 |
$1K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
256 |
251 |
$1K |
| 86901 |
|
368 |
342 |
$1K |
| 86900 |
|
369 |
343 |
$1K |
| 80051 |
|
243 |
230 |
$1K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
197 |
103 |
$989.76 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
54 |
52 |
$948.42 |
| 81003 |
|
476 |
466 |
$936.34 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
56 |
54 |
$927.68 |
| G0297 |
Low dose ct scan (ldct) for lung cancer screening |
15 |
15 |
$905.39 |
| 72040 |
|
72 |
71 |
$890.48 |
| 82746 |
|
127 |
125 |
$887.73 |
| 97162 |
|
255 |
248 |
$876.99 |
| 84520 |
|
279 |
268 |
$872.52 |
| 87075 |
|
194 |
179 |
$843.90 |
| 83550 |
|
232 |
227 |
$801.48 |
| 87070 |
|
223 |
203 |
$800.45 |
| 73110 |
|
100 |
97 |
$777.45 |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
29 |
28 |
$748.70 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
5,389 |
4,539 |
$746.93 |
| 86038 |
|
56 |
53 |
$707.68 |
| 96156 |
|
13 |
13 |
$700.65 |
| 73700 |
|
12 |
12 |
$694.40 |
| 97166 |
|
154 |
149 |
$656.81 |
| 87081 |
|
173 |
167 |
$598.17 |
| 82947 |
|
263 |
252 |
$588.49 |
| 80047 |
|
76 |
73 |
$560.86 |
| 84145 |
|
61 |
56 |
$537.56 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
3,584 |
2,508 |
$518.74 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
13 |
13 |
$502.92 |
| 82977 |
|
63 |
56 |
$444.11 |
| 76870 |
|
12 |
12 |
$390.92 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
1,419 |
698 |
$387.73 |
| 87205 |
|
161 |
149 |
$378.73 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
8,410 |
6,509 |
$378.64 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
3,101 |
2,742 |
$329.06 |
| 87430 |
|
76 |
72 |
$318.15 |
| J1644 |
Injection, heparin sodium, per 1000 units |
1,383 |
639 |
$314.17 |
| Q9963 |
High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml |
211 |
207 |
$285.66 |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
12 |
12 |
$278.32 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
332 |
234 |
$235.66 |
| 72110 |
|
12 |
12 |
$226.93 |
| 90715 |
|
17 |
16 |
$216.22 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,010 |
743 |
$215.67 |
| 73080 |
|
25 |
25 |
$202.40 |
| J7050 |
Infusion, normal saline solution, 250 cc |
2,692 |
1,702 |
$195.99 |
| 87147 |
|
13 |
12 |
$158.40 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
1,043 |
887 |
$158.23 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
101 |
60 |
$158.11 |
| 76937 |
|
58 |
56 |
$153.08 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
109 |
97 |
$152.53 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
3,278 |
2,609 |
$143.46 |
| 11102 |
|
15 |
13 |
$142.57 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
341 |
337 |
$142.01 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
43 |
38 |
$131.41 |
| 87340 |
|
15 |
14 |
$124.72 |
| 82140 |
|
45 |
40 |
$117.32 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,017 |
852 |
$109.58 |
| 76942 |
|
157 |
155 |
$95.04 |
| 80329 |
|
12 |
12 |
$92.73 |
| 73562 |
|
13 |
13 |
$90.75 |
| 94761 |
|
236 |
225 |
$79.70 |
| 80305 |
|
18 |
17 |
$79.02 |
| G0008 |
Administration of influenza virus vaccine |
12 |
12 |
$77.00 |
| 87210 |
|
28 |
26 |
$73.39 |
| 84550 |
|
14 |
13 |
$67.98 |
| J2060 |
Injection, lorazepam, 2 mg |
506 |
409 |
$67.63 |
| 36415 |
Collection of venous blood by venipuncture |
2,031 |
1,278 |
$64.20 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
355 |
198 |
$63.93 |
| 87102 |
|
16 |
15 |
$63.05 |
| C9399 |
Unclassified drugs or biologicals |
45 |
41 |
$62.66 |
| 82043 |
|
13 |
13 |
$61.60 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
293 |
244 |
$50.69 |
| 82270 |
|
14 |
14 |
$38.20 |
| 96376 |
|
258 |
150 |
$34.70 |
| J2704 |
Injection, propofol, 10 mg |
985 |
769 |
$33.35 |
| J3480 |
Injection, potassium chloride, per 2 meq |
193 |
59 |
$26.80 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
1,745 |
1,548 |
$25.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
1,631 |
1,594 |
$23.47 |
| 88304 |
|
135 |
134 |
$22.95 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
512 |
396 |
$19.35 |
| 97161 |
|
14 |
13 |
$16.38 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
1,178 |
654 |
$14.49 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
268 |
157 |
$10.35 |
| J1940 |
Injection, furosemide, up to 20 mg |
21 |
12 |
$7.20 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
68 |
38 |
$2.09 |
| A4216 |
Sterile water, saline and/or dextrose, diluent/flush, 10 ml |
52 |
48 |
$1.44 |
| Q0243 |
Injection, casirivimab and imdevimab, 2400 mg |
15 |
13 |
$0.05 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
28 |
25 |
$0.00 |
| J1756 |
Injection, iron sucrose, 1 mg |
72 |
39 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
120 |
92 |
$0.00 |
| S0028 |
Injection, famotidine, 20 mg |
100 |
71 |
$0.00 |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
197 |
186 |
$0.00 |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
154 |
154 |
$0.00 |
| J7999 |
Compounded drug, not otherwise classified |
1,336 |
950 |
$0.00 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
44 |
40 |
$0.00 |